| scholarly article | Q13442814 |
| P2093 | author name string | Kraus A | |
| Gómez E | |||
| Torres N | |||
| Bourges H | |||
| Tovar AR | |||
| Ortíz V | |||
| P2860 | cites work | Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases | Q33494448 |
| Hormones and the immune response | Q33561339 | ||
| Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes | Q33562953 | ||
| Transaminase activity in human blood | Q34236550 | ||
| Vitamin B-6: a status report | Q34262523 | ||
| 1990 McCollum Award lecture. Nutrition and immunity: lessons from the past and new insights into the future | Q37331283 | ||
| Cytokines and autoimmune disease | Q37433285 | ||
| Vitamins and the immune system | Q37936362 | ||
| Sjögren's syndrome. Proposed criteria for classification | Q39790521 | ||
| Single nutrients and immunity | Q40326939 | ||
| The regulation of prostaglandin E1 formation: A candidate for one of the fundamental mechanisms involved in the actions of vitamin C | Q41022199 | ||
| Nutrition and immunity with emphasis on infection and autoimmune disease | Q41062338 | ||
| Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren's syndrome | Q41529034 | ||
| Sjogren's syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C. | Q41647085 | ||
| Vitamin B-6 deficiency impairs interleukin 2 production and lymphocyte proliferation in elderly adults | Q43611352 | ||
| Effects of isoniazid treatment on human lymphocyte proliferative response, lymphocyte subsets and natural killer cell activity | Q59326443 | ||
| Immunoreactive interleukin-6 in serum of patients with B-lymphoproliferative diseases | Q67594798 | ||
| Association of the complement allele C4AQ0 with primary Sjögren's syndrome in Japanese patients | Q68197286 | ||
| Immunoreactive circulating alpha-interferon is low in Sjögren's syndrome | Q68714882 | ||
| Pyridoxine supplementation: effect on lymphocyte responses in elderly persons | Q68830282 | ||
| Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community | Q70607945 | ||
| Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases | Q71007119 | ||
| The diagnosis of pyridoxine deficiency based on the estimation of the erythrocytic aspartate aminotransferase and its stimulation in vitro with pyridoxal-5'-phosphate | Q71099447 | ||
| Treatment of the Sicca syndrome and Sjogren's syndrome with E.F.A., pyridoxine and vitamin C | Q71108243 | ||
| Phenotypic and functional abnormalities in the peripheral blood T-cells of patients with primary Sjogren's syndrome | Q72179838 | ||
| Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome | Q72329693 | ||
| RELATIONSHIP OF PYRIDOXINE TO IMMUNOLOGICAL PHENOMENA | Q78326044 | ||
| P433 | issue | 11 | |
| P921 | main subject | pyridoxine | Q423746 |
| P304 | page(s) | 1087-1093 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | European Journal of Clinical Nutrition | Q15756702 |
| P1476 | title | Biochemical deficiency of pyridoxine does not affect interleukin-2 production of lymphocytes from patients with Sjögren's syndrome | |
| P478 | volume | 56 |
Search more.